COO
Emcure Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Samit Mehta is recorded as COO at Emcure Pharmaceuticals Limited. Samit Mehta has spoken on 2 earnings calls across 1 company, most recently for Emcure Pharmaceuticals Limited on November 3, 2026. Emcure Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“The other product that we think will contribute significantly in Europe is Triprostilin.”
“I mean, Wistrad is obviously a lot going for that brand. A, it's an innovative brand. B, it's an RDNA, biologic versus the synthetic generics that have entered the market.”
Emcure Pharmaceuticals Limited
COO
Transcript header (unverified)
Emcure Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
COO
Earnings Call for the Quarter Ended September 30, 2026
Emcure Pharmaceuticals Limited
Earnings Call
Emcure Pharmaceuticals Limited
